The new suicide drug: Schering!
Bayer’s offer for Schering is more ridiculous than that made by Merck
One man’s loss is certainly another man’s gain. This sums up the story of companies bidding for pharma major, Schering AG. March 13, 2006 saw Merck making a hostile bid for acquiring Schering AG for $18.27 billion (a bid that had been thoroughly criticised by B&E, refer Stratagem section, issue dated March 24, 2006). On March 23, the story was different, as Bayer AG’s $19.9 billion bid at $104.25 per share compelled Merck to withdraw, making Bayer the sole bidder.
One man’s loss is certainly another man’s gain. This sums up the story of companies bidding for pharma major, Schering AG. March 13, 2006 saw Merck making a hostile bid for acquiring Schering AG for $18.27 billion (a bid that had been thoroughly criticised by B&E, refer Stratagem section, issue dated March 24, 2006). On March 23, the story was different, as Bayer AG’s $19.9 billion bid at $104.25 per share compelled Merck to withdraw, making Bayer the sole bidder.
Rashmi Bansal Publisher Of JAMMAG Magazine Caught Red-Handed, for details click on the following links.
- Hindustan Times Article - Publisher goes underground
- Rashmi Bansal (Editor of JAMMAG)
- Rashmi Bansal (Publisher of JAMMAG)
posted by IIPM @ 10:38 PM
<< Home